WAT
WATERS CORP /DE/
NYSE · Healthcare · Medical - Diagnostics & Research · US
$421.63
−1.88%Forward multiples
Based on analyst estimates
- P/E forward
- 27.01x
- P/E 2026E
- 29.01x
- P/E 2027E
- 25.62x
- P/E 2028E
- 22.99x
- P/S forward
- 6.02x
Trailing multiples
Trailing twelve months
- P/E TTM
- 104.88x
- PEG TTM
- 0.36x
- Price / book
- 2.73x
- Price / sales
- 8.92x
- Price / cash flow
- 75.34x
Enterprise value
- Enterprise value
- $46.1B
- EV / sales
- 9.93x
- EV / EBITDA
- 51.51x
- EV / EBIT
- 124.81x
- Market cap
- $41.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jul 1, 2026